Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionPartners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a P
BenzingaMar 29 12:43 ET
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementClinical-stage psychedelics biopharma c
BenzingaMar 20 14:49 ET
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized AnxietyPsilocybin-assisted therapy has hit a milestone as clinical trial results show potential benefits f
BenzingaMar 4 13:48 ET
Express News | HC Wainwright & Co. Reiterates Buy on GH Research, Maintains $40 Price Target
Moomoo 24/7Mar 4 13:08 ET
Buy Rating for GH Research: Promising Clinical Trials and Strategic Intellectual Property Advances
TipRanksMar 4 11:36 ET
Here's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success wi
Simply Wall StMar 2 08:54 ET
GH Research Price Target Cut to $39.00/Share From $50.00 by JMP Securities
GH Research Price Target Cut to $39.00/Share From $50.00 by JMP Securities
Dow JonesMar 1 12:01 ET
GH Research Is Maintained at Market Outperform by JMP Securities
GH Research Is Maintained at Market Outperform by JMP Securities
Dow JonesMar 1 12:01 ET
Express News | JMP Securities Maintains Market Outperform on GH Research, Lowers Price Target to $39
Moomoo 24/7Mar 1 11:52 ET
Oregon House Passes Bill to End Hard Drug Decriminalization
There are many factors in setting drug policy, which often center around the benefits or detriments to a society and its economy.
Seeking AlphaMar 1 06:42 ET
Buy Rating Justified by GH Research's Promising Clinical Trials and Strong Financial Health
TipRanksMar 1 01:36 ET
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Nasdaq-listed, GH Research (NASDAQ:GHRS) is a clinical-stage biopharma business developing novel 5-MeO-DMT therapies as transformative treatment of psychiatric and neurological disorders.Its reported
BenzingaFeb 29 22:47 ET
GH Research: Q4 Earnings Insights
GH Research (NASDAQ:GHRS) reported its Q4 earnings results on Thursday, February 29, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsGH Research missed estimated ear
BenzingaFeb 29 08:00 ET
GH Research GAAP EPS of -$0.68
Seeking AlphaFeb 29 07:45 ET
Express News | GH Research Reports FY23 Net Loss Of $(35.6)M, Or EPS Loss Of $(0.68) Vs. $(22.5)M, Or $(0.43) The Prior Year
Moomoo 24/7Feb 29 07:19 ET
GH Research 2023 Research and Development Expenses $29.8M >GHRS
GH Research 2023 Research and Development Expenses $29.8M >GHRS
Dow JonesFeb 29 07:11 ET
Press Release: GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates -- Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected c
Dow JonesFeb 29 07:00 ET
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last MonthsA new study suggests a potential link between the use of psychedelics like magic mushrooms and LSD
BenzingaFeb 15 08:36 ET
Psychedelic Stocks Gain After FDA Priority Review for MDMA Therapy
Seeking AlphaFeb 12 12:13 ET
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
New Study Reveals Suggestibility's Role In Antidepressant Effects Of Psilocybin TherapyA new study led by Balázs Szigeti and with involvement of researchers Brandon Weiss, Fernando E Rosas, David Err
BenzingaJan 27 10:00 ET
No Data
No Data